Access to Innovative Medicines at the State Level

Legislation at the state level in the last year has had a significant impact on accessing innovative medicines.   Join speakers as they discuss a host of access issues at the state level including biomarkers, access to vaccines, PDAPs, and the accelerated approval pathway.